数据链接：
官方服务：
资源简介：
CCLE PharmacoSet (PSet) generated by ORCESTRA. Metadata can be found on ORCESTRA at: http://orcestra.ca/10.5281/zenodo.3848193
应用场景：
创建时间：
2020-05-26
相关数据集
The landscape of pharmacogenomic interactions in human cancer
Systematic studies of the cancer genome are providing unprecedented insights into the molecular nature of human cancer. Using this information to guide the development and application of therapies in
NIAID Data Ecosystem80
Supplementary Table 4 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
Enrichment of DNF drug communities
NIAID Data Ecosystem50
DataSheet1_Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients.pdf
Tamoxifen (TAM), a selective oestrogen receptor modulator, is one of the most used treatments in oestrogen receptor-positive (ER+) early and metastatic breast cancer (BC) patients. The response to TAM
NIAID Data Ecosystem30
Fig A Hierarchical cluster dendrogram for the pairwise Pearson correlation coefficients of the CGP data; Fig B Heatmap of GI50 correlations for the CGP data; Fig C Glmnet EN regression output for PD-0325901; Fig D Heatmap for CGP drugs that yielded a converged EN model with 10 or more genes; Fig E: Heatmap for minimal EN model of bortezomib; Table A.
Pvclust result for GI50 measures in the CGP tumor cells; Table B. Cluster results for EN genes; Table C. GSEA results for minimal EN models of PD_0325901; Table D. GSEA results for the minimal EN gene
NIAID Data Ecosystem50
Additional file 14 of Machine learning approach informs biology of cancer drug response
Additional file 14. Supplementary Table S12. Top 20 GO Biological Processes enrichment of elastic-net derived genes for PTX analysis without blood cancers. P-values shown are uncorrected for multiple
Figshare2022-05-17 更新40
